These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
935 related articles for article (PubMed ID: 34622445)
1. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006466. PubMed ID: 34622445 [TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Barba M; Yosuico VED; Terrenato I; Sperati F; Schünemann H; Akl EA Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006466. PubMed ID: 29285754 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657 [TBL] [Abstract][Full Text] [Related]
11. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulation for people with cancer and central venous catheters. Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. Forster R; Stewart M Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384 [TBL] [Abstract][Full Text] [Related]
15. Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis. Al Said S; Kaier K; Sumaya W; Alsaid D; Duerschmied D; Storey RF; Gibson CM; Westermann D; Alabed S Cochrane Database Syst Rev; 2024 Jan; 1(1):CD014678. PubMed ID: 38264795 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027 [TBL] [Abstract][Full Text] [Related]
20. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis. Wang X; Ma Y; Hui X; Li M; Li J; Tian J; Wang Q; Yan P; Li J; Xie P; Yang K; Yao L Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010956. PubMed ID: 37058421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]